Covered recipient · General Payments record
GINA MATACIA
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$4,372.58
- Reported across 62 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $210.93 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $52.20 | 3 |
| GlaxoSmithKline, LLC. | $36.75 | 2 |
| ABBVIE INC. | $33.75 | 1 |
| Rigel Pharmaceuticals, Inc. | $26.75 | 2 |
| AVEO Pharmaceuticals, Inc. | $21.71 | 1 |
| Alexion Pharmaceuticals, Inc. | $20.38 | 1 |
| Acerta Pharma LLC | $19.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.75 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981677 | CMS |
| Alexion Pharmaceuticals, Inc. | $20.38 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093952616 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.39 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104649223 | CMS |
| Aveo Pharmaceuticals, Inc. | $21.71 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143477765 | CMS |
| GlaxoSmithKline, LLC. | $14.53 | 04/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116517950 | CMS |
| GlaxoSmithKline, LLC. | $22.22 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115918213 | CMS |
| PFIZER INC. | $14.56 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131119564 | CMS |
| PFIZER INC. | $19.48 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131322151 | CMS |
| PFIZER INC. | $18.16 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131355391 | CMS |
| Rigel Pharmaceuticals, Inc. | $12.66 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145201128 | CMS |
| Rigel Pharmaceuticals, Inc. | $14.09 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145209259 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.